Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Melanoma × Salvage Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Prostatic Neoplasms 2 Recurrence 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Erythroblastic, Acute 1 Hodgkin Disease 1 Brain Neoplasms 1

Interventions

pembrolizumab 256 Nivolumab 228 Ipilimumab 208 Cyclophosphamide 124 aldesleukin 123 Interleukin-2 91 Dacarbazine 68 trametinib 66 Temozolomide 65 fludarabine 63 Vemurafenib 63 dabrafenib 59 fludarabine phosphate 56 Radiosurgery 43 Biopsy 40 sargramostim 39 Bevacizumab 39 binimetinib 37 incomplete Freund's adjuvant 36 Paclitaxel 35 Cisplatin 34 Radiotherapy 32 encorafenib 31 atezolizumab 31 cobimetinib 30 Magnetic Resonance Spectroscopy 30 Carboplatin 29 Introns 28 Specimen Handling 27 CTLA-4 Antigen 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡